Background: In recent years, various noninvasive respiratory support (NRS) of ventilation has been provided more in neonates. The aim of this study was to compare the effect of HFNC with NCPAP in post-extubation of preterm infants with RDS after INSURE method (intubation, surfactant, extubation).Methods: A total of 54 preterm infants with RDS (respiratory distress syndrome) were enrolled in thi...

Despite recent advances in the perinatal management of neonatal respiratory distress syndrome (RDS), controversies still exist. We report updated recommendations of a European Panel of expert neonatologists who developed consensus guidelines after critical examination of the most up-to-date evidence in 2007 and 2010. This second update of the guidelines is based upon published evidence up to th...

introduction: the risk of morbidity and mortality increases in neonates admitted to the neonatal intensive care units (nicus). various factors contribute to the prognosis of these newborns. in the current study, we aimed to investigate the role of mode of delivery on short-term neonatal outcomes. methods: this retrospective study was conducted on 215 neonates admitted to the nicu of shohada-e-t...

Surfactant replacement therapy (SRT) has long become the standard of care in treatment neonatal respiratory distress syndrome (RDS), significantly decreasing acute pulmonary morbidity and mortality preterm infants. For decades, this beneficial been administered via endotracheal tube. Despite improving outcome RDS, however, burden bronchopulmonary dysplasia remains, particular, very immature Ack...

Background: Respiratory distress syndrome (RDS) is a medical emergency in infants resulting from a lack of or deficiency in surfactant, and leads to pulmonary failure. Surfactant and mechanical ventilation are among the primary treatments for helping infants with respiration. Some sedative drugs, such as benzodiazepines and opioids, are used to reduce stress and restlessness in...

Background: Early nasal continuous positive airway pressure (NCPAP) has emerged as a primary modality of respiratory support for preterm infants withrespiratory distress syndrome (RDS). However, 30%-40% of these newborns need subsequent mechanical ventilation. Nasal intermittent positive pressure ventilation (NIPPV) is a promising alternative to NCPAP, especially in po...

Received June 28, 2000 Pulmonary surfactant is routinely used in immature newborns for the prevention and treatment of respiratory distress syndrome (RDS). Inhaled nitric oxide (INO) is a new respiratory therapy, recently approved by the Food and Drug Administration, for selective pulmonary vasodilation in persistent pulmonary hypertension of the newborns (PPHN) and in hypoxic respiratory failu...